The science of when you should exercise to beat obesity

A new paper in Obesity explores the diurnal relationship of obesity to MVPA – at what time does MVPA pay off the most in preventing obesity?

The promising role of GLP-1RAs in NASH – Pharmaceutical Technology

Non-alcoholic steatohepatitis (NASH) is a progressive form of non-alcoholic fatty liver disease (NAFLD), characterised by liver inflammation and fibrosis. Credit: Vitalii Vodolazskyi via Shutterstock. Incretin

June 28, 2023

Is your body clock the secret to peak athletic performance?

Review comprehensively explores how the circadian rhythm impacts sports performance, hormonal regulation, and immune system function in athletes. The study emphasizes the optimal times of

September 7, 2023

FTC May Intervene in Epic Systems Antitrust Lawsuit

What You Should Know: – During a visit to Wisconsin focused on corporate consolidation in the grocery industry, Federal Trade Commission (FTC) Chairwoman Lina Khan

October 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.